Finally, cancer cells are often addicted to the presence of mutant p53 for survival and metastasis, and abrogation of many of the acquired gain-of-functions (GOF) of mutant p53 can reduce addiction and metastasis, thereby inducing tumor cell death and tumor load in vivo [26–32]. Here, TP53 is linked to cancer.